Skip to main content

WestCX Elevates Pharmacy Operations with New Agentic AI Solution

Written by Customer Service on . Posted in Public Companies.

Strategic AI for Enhanced Adherence, Efficiency, and Revenue Growth

OMAHA, Neb., Oct. 21, 2025 (GLOBE NEWSWIRE) — WestCX, part of the West Technology Group, today announced the launch of its agentic AI solution engineered to optimize pharmacy-patient interactions. The solution enables pharmacies to automate patient communications, improve medication adherence, and reduce operational strain.

Available through WestCX’s Mosaicx and TeleVox brands, it blends conversational AI with agentic capabilities to deliver personalized patient interactions across channels via the company’s secure platform.

The solution reduces the burden of answering repetitive inbound calls through conversational AI, enabling staff to focus on critical patient care. Its agentic AI capabilities tailor outreach based on patient behavior and context, ensuring every interaction is personalized to increase loyalty and trust. These enhancements empower pharmacies to proactively manage prescription refills, pickup reminders, and vaccine outreach while delivering faster, more connected experiences for patients.

Early adopters are already seeing transformative impacts including:

  • Up to 80% automation of standard inquiries (refills, status, FAQs), freeing up resources for core operations
  • 20–35% increase in refill rates through timely, personalized outreach
  • Higher medication adherence and completed vaccine series
  • Thousands of staff hours saved annually through automated inbound and outbound communication, reducing burnout

“Pharmacies sit at the front line of patient care, yet their teams are often stretched thin managing administrative and repetitive tasks,” said Sam Meckey, president of WestCX. “With this solution, those fragmented interactions become seamless and directly support critical operational metrics like improved medication adherence and reduced return-to-stock events. Patients get the right message and care at the right time, and pharmacies see stronger loyalty, higher foot traffic, and proven revenue growth.”

The new solution equips patients with intuitive tools for seamless experiences, including smart map links to simplify pickups, integrated web payments for faster checkout, and pickup barcodes to reduce wait times in store. For pharmacies, the solution’s embedded analytics and AI-driven optimization refine performance over time, driving higher ROI and sustained adherence over time.

To learn more about the new agentic pharmacy solution, visit www.westcx.com to request a demo.

About WestCX
WestCX, under the West Technology Group, LLC portfolio, is a cloud-based technology partner providing AI-powered omnichannel solutions. The WestCX brand includes Mosaicx and TeleVox, solutions that automate interactions and optimize engagements, improving efficiency and customer and patient satisfaction. With over 30 years of experience delivering enterprise CX solutions, the company’s expertise includes innovative digital patient relationship management and conversational AI solutions. West Technology Group is controlled by affiliates of certain funds managed by Apollo Global Management, Inc. (NYSE: APO).

Media Contact 
Lucy Meneghello
Communiqué PR
MosaicxPR@communiquepr.com
206-282-4923 ext. 129

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.